OpenAI’s new FrontierScience benchmark shows AI advancing in physics, chemistry, and biology—and exposes the challenge of ...

OpenAI has cut down the time and resources needed for identifying and mitigating risks while testing its artificial intelligence models, as pressure mounts to speed up new model launches amid ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...

Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical ...

In my last few articles, I've been dipping into the waters of "machine learning"—a powerful idea that has been moving steadily into the mainstream of computing, and that has the potential to change ...